Search
In this new blog, Speech Pathologist Emma Corry looks at the importance of shared attention for connection, communication and learning.
The Infectious Disease Ecology and Modelling team led by Professor Nick Golding, combines mathematical and statistical modelling, ecology, and public health to address malaria and other infectious and vector-borne diseases. The team uses modelling and maps to measure the risk posed by some of the world’s most important and neglected diseases – including malaria, Japanese Encephalitis and COVID-19 – and provide rapid modelling analyses to policy makers.
The Geospatial and Tuberculosis (GeoTB) team led by Kefyalew Alene focuses on designing an innovative approach for improving the efficiency and effectiveness of public health interventions to help control and ultimately eliminate tuberculosis in high-burden countries.
The Department for Education commissioned this report to understand how such gender differences in early childhood may influence outcomes later in life.
ORIGINS has officially reached the study's five-year goal of recruiting 4,000 active participants to the project and has closed recruitment of new families into the active cohort.
In 2016, the Australian Centre for Child Protection (ACCP) and The Kids Research Institute Australia (The Kids) were engaged to evaluate the implementation and impact of Triple P in South Australia.
In 2021 the South Australian Department for Education commissioned The Kids Research Institute Australia to undertake a review of the Hearing Impairment Support Program (HISP).
CliniKids is committed to involving consumers and the community in all aspects of our research and service delivery. One way we do this is by providing the opportunity for consumers and community members to contribute through our community reference groups.
Frangipani Family Day is an opportunity for CliniKids to celebrate the families we engage with through our clinical services and research.
The Penicillin Team are working to accelerate research and clinical trials to improve penicillin formulation and treatment methods, to end RHD.